Joseph F. Contrera

3.4k citations

64 papers · 2.5k indexed · h-index 32

Computational Theory and Mathematics top 0.5%
Molecular Biology top 10%
Cellular and Molecular Neuroscience top 5%
Cancer Research top 5%
Health, Toxicology and Mutagenesis top 5%

Co-authors: Edwin J. Matthews R. Benz Naomi L. Kruhlak M. J. Kuhar Jay Simon M. Goldstein Albert S. Gordon E B De Souza
Topics: Computational Drug Discovery Methods (19 papers)Carcinogens and Genotoxicity Assessment (15 papers)Neurotransmitter Receptor Influence on Behavior (8 papers)
Cited by: Chemical Health and Safety Computational Theory and Mathematics Toxicology
Journals: Nature Science Journal of Biological Chemistry
Partner nations: United States Sweden France

In The Last Decade

Joseph F. Contrera

64 papers receiving 2.3k citations

Peers

Countries citing papers authored by Joseph F. Contrera

Since Specialization

Citations

This map shows the geographic impact of Joseph F. Contrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph F. Contrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph F. Contrera more than expected).

Fields of papers citing papers by Joseph F. Contrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph F. Contrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph F. Contrera. The network helps show where Joseph F. Contrera may publish in the future.

Co-authorship network of co-authors of Joseph F. Contrera

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph F. Contrera. A scholar is included among the top collaborators of Joseph F. Contrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph F. Contrera. Joseph F. Contrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals 2013 ·Regulatory Toxicology and Pharmacology ·Joseph F. Contrera	27
2	Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities 2009 ·Regulatory Toxicology and Pharmacology ·(unknown),Naomi L. Kruhlak,Joseph F. Contrera,(unknown),R. Benz,Edwin J. Matthews	32
3	Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities 2009 ·Regulatory Toxicology and Pharmacology ·Edwin J. Matthews,Naomi L. Kruhlak,R. Benz,(unknown),Carol A. Marchant,Joseph F. Contrera	32
4	In silicoapproaches to explore toxicity end points: issues and concerns for estimating human health effects 2007 ·Expert Opinion on Drug Metabolism & Toxicology ·Edwin J. Matthews,Joseph F. Contrera	24
5	A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database 2007 ·Regulatory Toxicology and Pharmacology ·Edwin J. Matthews,Naomi L. Kruhlak,R. Benz,Joseph F. Contrera	33
6	Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling 2007 ·Toxicology and Applied Pharmacology ·Luis G. Valerio,Kirk Arvidson,Ronald Chanderbhan,Joseph F. Contrera	56
7	Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models 2007 ·Regulatory Toxicology and Pharmacology ·Joseph F. Contrera,Naomi L. Kruhlak,Edwin J. Matthews,R. Benz	46
8	A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals 2006 ·Regulatory Toxicology and Pharmacology ·Edwin J. Matthews,Naomi L. Kruhlak,R. Benz,Julian Ivanov,Gilles Klopman,Joseph F. Contrera	50
9	Genetic Toxicity Assessment: Employing the Best Science for Human Safety Evaluation Part I: Early Screening for Potential Human Mutagens 2006 ·Toxicological Sciences ·David Jacobson‐Kram,Joseph F. Contrera	29
10	QSAR Modeling of Carcinogenic Risk Using Discriminant Analysis and Topological Molecular Descriptors 2005 ·Current Drug Discovery Technologies ·Joseph F. Contrera,(unknown),Lowell H. Hall,Lemont B. Kier	43
11	In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software 2005 ·Regulatory Toxicology and Pharmacology ·Joseph F. Contrera,Edwin J. Matthews,Naomi L. Kruhlak,R. Benz	42
12	An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods 2005 ·Regulatory Toxicology and Pharmacology ·Edwin J. Matthews,Naomi L. Kruhlak,Michael C. Cimino,R. Benz,Joseph F. Contrera	71
13	Assessment of the Health Effects of Chemicals in Humans: II. Construction of an Adverse Effects Database for QSAR Modeling 2004 ·Current Drug Discovery Technologies ·Edwin J. Matthews,Naomi L. Kruhlak,James L. Weaver,R. Benz,Joseph F. Contrera	28
14	Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose 2004 ·Regulatory Toxicology and Pharmacology ·Joseph F. Contrera,Edwin J. Matthews,Naomi L. Kruhlak,R. Benz	66
15	Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices 2003 ·Regulatory Toxicology and Pharmacology ·Joseph F. Contrera,Edwin J. Matthews,R. Benz	79
16	A New Highly Specific Method for Predicting the Carcinogenic Potential of Pharmaceuticals in Rodents Using EnhancedMCASEQSAR-ES Software 1998 ·Regulatory Toxicology and Pharmacology ·Edwin J. Matthews,Joseph F. Contrera	106
17	In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals. 1998 ·Environmental Health Perspectives ·Joseph F. Contrera,J J DeGeorge	25
18	Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals 1997 ·Regulatory Toxicology and Pharmacology ·Joseph F. Contrera,Abigail Jacobs,Joseph J. DeGeorge	88
19	Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Robert Zaczek,Giuseppe Battaglia,Steven Culp,N M Appel,Joseph F. Contrera,E B De Souza	101
20	Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamine 1989 ·Toxicology and Applied Pharmacology ·Robert Zaczek,George Battaglia,Joseph F. Contrera,Steven Culp,Errol B. De Souza	34

About Joseph F. Contrera

Joseph F. Contrera is a scholar working on Chemical Health and Safety, Computational Theory and Mathematics and Toxicology, having authored 64 papers that have together received 2.5k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (19 papers), Carcinogens and Genotoxicity Assessment (15 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). The work is most often cited by research in Chemical Health and Safety (36 citations), Computational Theory and Mathematics (818 citations) and Toxicology (119 citations). Joseph F. Contrera has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Edwin J. Matthews, R. Benz, Naomi L. Kruhlak, M. J. Kuhar, Jay Simon, M. Goldstein, Albert S. Gordon, E B De Souza, N M Appel and Michael C. Cimino. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact